PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE

The update on the WHO classification of central nervous system (CNS) tumors incorporated molecular signatures for a more accurate diagnosis. Recently, DKFZ has demonstrated the utility of DNA methylation profiling(MP) for molecular classification of CNS tumors. We performed a prospective clinical st...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Karimi, Shirin, Zuccato, Jeffrey, Mamatjan, Yasin, Mansouri, Sheila, Suppiah, Suganth, Nassiri, Farshad, Diamandis, Phedias, Munoz, David, Aldape, Kenneth, Zadeh, Gelareh
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Molecular Pathology and Classification - Adult and Pediatric
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847817/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.617
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares